About Sound Pharmaceuticals, Inc.

Sound Pharmaceuticals (SPI) is a privately held biopharmaceutical company in Seattle, WA. Our goal is to develop prescription drugs that will enable doctors and patients to prevent and treat hearing loss, a disease that affects over 30 to 40 million Americans. Estimates from the NIH and the CDC place the total annual costs of hearing loss at approximately $50 billion per year in the U.S. alone.

Currently, there are no FDA approved drugs that protect or restore your hearing from noise damage, ototoxic drugs or aging.

 

About Sound Pharmaceuticals, Inc.

About Sound Pharmaceuticals, Inc.